688235:SHA
BeOne Medicines AG
240,36Â CNY
arrow_downward
-1,49%(-3,64) 1d
14 d’oct., 9:50:35 GMT+8 · CNY
search
Tots els sÃmbols
| SÃmbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadÃstiques principals per a 688235...
Obre
243,75Â CNY
Alt
245,45Â CNY
Baix
239,41Â CNY
Capitalització borsà ria
286,80Â kM
Volum mitjÃ
2,94Â M
Volum
430,38Â k
RÃ tio preu-benefici
85,85
Alt 52 setmanes
319,24Â CNY
Baix 52 setmanes
205,51Â CNY
BPA
2,80Â CNY
Nombre d'empleats
12Â k
Obre
243,75Â CNY
Alt
245,45Â CNY
Baix
239,41Â CNY
Capitalització borsà ria
286,80Â kM
Volum mitjÃ
2,94Â M
Volum
430,38Â k
RÃ tio preu-benefici
85,85
Alt 52 setmanes
319,24Â CNY
Baix 52 setmanes
205,51Â CNY
BPA
2,80Â CNY
Nombre d'empleats
12Â k
NotÃcies
De fonts web i partners de notÃcies
La Nación
·
fa 5 hores
How major US stock indexes fared Tuesday 10/13/2026
MarketBeat
·
fa 32 minuts
Liquidia (NASDAQ:LQDA) Insider Sells 9,218 Shares of Company Stock
Yahoo Finance
·
fa 2 hores
S&P 500 Ends Flat, While Nasdaq Drops As Memory Chipmakers Sell Off — BAC, GME, SPCX, ARM, QCOM In Focus
BigGo Finance
·
fa 1 hora
NY Stocks Fall as Dow Drops 180 Points; Crude Rises $1.10 on Middle East Concerns
Perfil
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024, the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
Sobre BeOne Medicines AG
Conseller delegatJohn Vincent Oyler | John Vincent Oyler
Empleats12Â k
Fundació28 d’oct. 2010
Seu principal-
Sector-
Lloc webbeonemedicines.com